As a member of the Business, Energy and Industrial Strategy Committee, I met some pharmaceutical companies. One thing they told us, which was quite stark, was that research and development
is done in this country, and manufacturing in the Republic of Ireland, and the product is then transferred back to the UK to go to mainland Europe. They will be paying tariffs perhaps half a dozen times, adding costs to our NHS.